Knowledge and perceptions of BRCA1/2 genetic testing and needs of diverse women with a personal or family history of breast cancer in South Florida

被引:2
|
作者
Jones, Tarsha [1 ]
Howard, Heather [2 ]
Freeman-Costin, Katherine [3 ]
Creighton, Ana [1 ]
Wisdom-Chambers, Karen [1 ]
Underhill-Blazey, Meghan [4 ,5 ]
机构
[1] Florida Atlantic Univ, Christine E Lynn Coll Nursing, 777 Glades Rd, Boca Raton, FL 33431 USA
[2] Florida Atlantic Univ, Coll Design & Social Inquiry, Boca Raton, FL 33431 USA
[3] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA
[4] Univ Rochester, Sch Nursing, 601 Elmwood Ave, Rochester, NY 14642 USA
[5] Dana Farber Canc Inst, Boston, MA 02215 USA
关键词
Breast cancer; BRCA1 and BRCA2; Genetic testing; Diverse women; Personal or family history; Qualitative research;
D O I
10.1007/s12687-021-00507-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The vast majority of (BRCA1/2) genetic testing has been conducted in White women, in particular Ashkenazi Jewish women, with limited information available for Black and Hispanic women. Understanding perspectives of those who are underserved is critical to developing interventions to support inclusive approaches to genetic testing. This qualitative study explored knowledge and perceptions of BRCA1/2 genetic testing among diverse women in South Florida. We also explored participants' information needs. Convenience sampling was used to recruit a diverse group of 15 women with a personal or family history of breast cancer. We conducted semi-structured interviews and used grounded theory method to analyze the data. Five themes were identified: (1) lacking awareness and knowledge of BRCA1/2 genetic testing and results among Black women, (2) perceiving BRCA1/2 genetic testing as beneficial to themselves and a way to be proactive about cancer risk, (3) perceiving BRCA1/2 genetic testing as beneficial to family members, (4) interactions with healthcare providers and the healthcare system that shape genetic testing experiences, and (5) information needs for reducing cancer risk and promoting health. Our findings suggest that diverse underserved women perceived genetic testing as beneficial to themselves and family members. Women needed more information about the BRCA genes and genetic testing, prevention strategies, and the latest breast cancer research. Healthcare providers, particularly nurse practitioners, need to engage diverse high-risk women in discussions about their cancer risk, address unmet information needs, and, in particular, educate Black women about the benefits of pursuing genetic testing.
引用
收藏
页码:415 / 429
页数:15
相关论文
共 50 条
  • [1] Knowledge and perceptions of BRCA1/2 genetic testing and needs of diverse women with a personal or family history of breast cancer in South Florida
    Tarsha Jones
    Heather Howard
    Katherine Freeman-Costin
    Ana Creighton
    Karen Wisdom-Chambers
    Meghan Underhill-Blazey
    [J]. Journal of Community Genetics, 2021, 12 : 415 - 429
  • [2] Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2
    Bluman, LG
    Rimer, BK
    Berry, DA
    Borstelmann, N
    Iglehart, JD
    Regan, K
    Schildkraut, J
    Winer, EP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 1040 - 1046
  • [3] CONTRALATERAL MASTECTOMY AND BRCA1 AND BRCA2 Threshold for genetic testing in women with breast cancer needs to be determined
    Basu, Narendra Nath
    Barr, Lester
    Evans, D. Gareth
    Ross, Gary L.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [4] Quality of life for women seeking BRCA1/2 genetic testing: Impact of family cancer history
    Lesniak, KT
    Keenan, LA
    Guarnaccia, CA
    Althaus, BW
    Ethington, GM
    Blum, JL
    [J]. PSYCHOSOMATIC MEDICINE, 2001, 63 (01) : 126 - 127
  • [5] Predictors of psychological distress for women seeking BRCA1/BRCA2 genetic testing: Impact of family cancer history
    Lesniak, KT
    Keenan, LA
    Guarnaccia, CA
    Althaus, BW
    Ethington, GM
    Blum, JL
    [J]. PSYCHOSOMATIC MEDICINE, 2001, 63 (01) : 127 - 127
  • [6] Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer
    Armstrong, K
    Micco, E
    Carney, A
    Stopfer, J
    Putt, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (14): : 1729 - 1736
  • [7] Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2
    Phillips, KA
    Warner, E
    Meschino, WS
    Hunter, J
    Abdolell, M
    Glendon, G
    Andrulis, IL
    Goodwin, PJ
    [J]. CLINICAL GENETICS, 2000, 57 (05) : 376 - 383
  • [8] Family communication of genetic test results and uptake of genetic testing in a diverse population of BRCA1 and BRCA2 (BRCA1/2) carriers
    Fehniger, J.
    Lin, F.
    Beattie, M.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : S22 - S23
  • [9] Breast pathology in women with personal and family history of breast cancer, including BRCA1/2 mutation carriers: a model for cancer progression.
    Adem, C
    Soderberg, CL
    Reynolds, C
    Slezak, JM
    Schaid, DJ
    Johnson, JL
    Kuntz, LM
    Kuntz, LM
    Anderl, KL
    Sellers, TA
    Hartmann, LC
    Jenkins, RB
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 236 - 236
  • [10] Family Communication of BRCA1/2 Results and Family Uptake of BRCA1/2 Testing in a Diverse Population of BRCA1/2 Carriers
    Fehniger, Julia
    Lin, Feng
    Beattie, Mary S.
    Joseph, Galen
    Kaplan, Celia
    [J]. JOURNAL OF GENETIC COUNSELING, 2013, 22 (05) : 603 - 612